Revenue ($USD) : $5,549,000,000
R&D spend : $339,000,000
Employees : 18,452
Fiscal year end : 12/31/2023
CEO : Deepak Nath

www.smith-nephew.com

Smith+Nephew is the world’s fifth-largest orthopedic device company. In 2024, S+N introduced new artificial intelligence features for its Cori orthopedic surgical robotic system to boost personalization and efficiency of knee and hip arthroplasty procedures. Other top S+N news for the year included the full U.S. launch of its Aetos shoulder system with additional FDA clearances, plus FDA clearance of its new Catalystem primary hip system. –CN